-
Abstract Number: 314
Pre-treatment Screening for Hepatitis B and C Among Users of Biologics or New Synthetic Disease Modifying Drugs: An Analysis Using RISE Data
-
Abstract Number: 315
Improving the Rate of Tuberculosis Screening Among High Risk Rheumatoid Arthritis Patients on Biologic Agents Using a Proposed Questionnaire
-
Abstract Number: 316
Implementation of Cardiovascular Screening in Hispanic Patient Population with RA, SLE and PsA
-
Abstract Number: 317
Improving Adherence to Pregnancy Screening in Patients on Teratogenic Medications Using an Electronic Medical Record Alert System: A Quality Improvement Initiative
-
Abstract Number: 318
Improving Safe Prescribing of Hydroxychloroquine in a Safety Net Hospital Rheumatology Clinic
-
Abstract Number: 319
A Pragmatic Randomized Trial to Improve Safe Dosing of Hydroxychloroquine
-
Abstract Number: 320
Hydroxychloroquine (HCQ) Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution
-
Abstract Number: 321
Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Rheumatoid Arthritis and Systemic Lupus Erythematosus
-
Abstract Number: 322
Hydroxychloroquine Retinal Screening and Dosing in an Unique Rheumatologic Patient Population
-
Abstract Number: 323
Compliance with Hydroxychloroquine Dosage According to 2016 American Academy of Ophthalmology (AAO) Guidelines: A Study with 6591 Patients
-
Abstract Number: 324
Adherence to Guideline Directed Management of Gout Among VA Providers
-
Abstract Number: 325
Frailty and Sarcopenia in Inflammatory Rheumatic Disease
-
Abstract Number: 326
Cardiac Sarcoidosis Awareness: Are We Underdiagnosing?
-
Abstract Number: 327
Presentation Order Bias in Rheumatology Journals: A Content Analysis
-
Abstract Number: 328
Adverse Events During Colchicine Use: A Systematic Review and Meta-Analysis of Randomized Controlled Trial Events
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 198
- Next Page »